| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3396154 | Antibiotiques | 2007 | 9 Pages |
Abstract
Based on the experience with existing vaccines, the development of mucosal immunity or administration of vaccines via the mucosal route is clearly not a prerequisite today for control or prevention of most viral infectious respiratory diseases or diseases with respiratory tract as a route of contamination. But the example of live attenuated intranasal influenza vaccine inducing both systemic and local immune response without immunopathology, is promising for the future of the mucosal immunization against respiratory viral infections.
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
F. Denis, S. Hantz, S. Alain,